Matches in SemOpenAlex for { <https://semopenalex.org/work/W2131621311> ?p ?o ?g. }
- W2131621311 endingPage "e16" @default.
- W2131621311 startingPage "e2" @default.
- W2131621311 abstract "Background: Rituximab has increasingly been used for the treatment of hematological malignancies and autoimmune diseases, and its efficacy and safety are well established. Although clinical trials have shown conflicting results regarding the association of rituximab with infections, an increased incidence of infections has recently been reported in patients with lymphomas being treated with rituximab. However, clinical experience regarding the association of rituximab with different types of infection is lacking and this association has not been established in patients with rheumatoid arthritis.Methods: All previous studies included in our literature review were found using a PubMed, EMBASE, and Cochrane database search of the English-language medical literature applying the terms ‘rituximab’, ‘monoclonal antibodies’, ‘infections’, ‘infectious complications’, and combinations of these terms. In addition, the references cited in these articles were examined to identify additional reports.Results: We performed separate analyses of data regarding the association of rituximab with infection in (1) patients with hematological malignancies, (2) patients with autoimmune disorders, and (3) transplant patients. Recent data show that rituximab maintenance therapy significantly increases the risk of both infection and neutropenia in patients with lymphoma or other hematological malignancies. On the other hand, data available to date do not indicate an increased risk of infections when using rituximab compared with concurrent control treatments in patients with rheumatoid arthritis. However, there is a lack of sufficient long-term data to allow such a statement to be definitively made, and caution regarding infections should continue to be exercised, especially in patients who have received repeated courses of rituximab, are receiving other immunosuppressants concurrently, and in those whose immunoglobulin levels have fallen below the normal range. Few data are available concerning the risk of organ transplant recipients developing infections following rituximab therapy. Data from case reports, case series, and retrospective studies correlate rituximab use with the development of a variety of infections in transplant patients.Conclusions: Further studies are needed to clarify the association of rituximab with infection. Physicians and patients should be educated about the association of rituximab with infectious complications. Monitoring of absolute neutrophil count and immunoglobulin levels and the identification of high-risk groups for the development of infectious complications, with timely vaccination of these groups, are clearly needed." @default.
- W2131621311 created "2016-06-24" @default.
- W2131621311 creator A5019379026 @default.
- W2131621311 creator A5025805658 @default.
- W2131621311 creator A5038285556 @default.
- W2131621311 creator A5085723076 @default.
- W2131621311 date "2011-01-01" @default.
- W2131621311 modified "2023-10-12" @default.
- W2131621311 title "Does rituximab increase the incidence of infectious complications? A narrative review" @default.
- W2131621311 cites W1158258141 @default.
- W2131621311 cites W1510382284 @default.
- W2131621311 cites W1521715232 @default.
- W2131621311 cites W1603245933 @default.
- W2131621311 cites W161677733 @default.
- W2131621311 cites W1785971308 @default.
- W2131621311 cites W1963959614 @default.
- W2131621311 cites W1965637696 @default.
- W2131621311 cites W1966831995 @default.
- W2131621311 cites W1971548861 @default.
- W2131621311 cites W1971850723 @default.
- W2131621311 cites W1974021055 @default.
- W2131621311 cites W1974712387 @default.
- W2131621311 cites W1975280591 @default.
- W2131621311 cites W1975976410 @default.
- W2131621311 cites W1976285978 @default.
- W2131621311 cites W1978235999 @default.
- W2131621311 cites W1987631597 @default.
- W2131621311 cites W1988217711 @default.
- W2131621311 cites W1990317890 @default.
- W2131621311 cites W1991006874 @default.
- W2131621311 cites W1994630947 @default.
- W2131621311 cites W1995588846 @default.
- W2131621311 cites W1996121692 @default.
- W2131621311 cites W2001989177 @default.
- W2131621311 cites W2002712930 @default.
- W2131621311 cites W2004670542 @default.
- W2131621311 cites W2004831687 @default.
- W2131621311 cites W2007836097 @default.
- W2131621311 cites W2008227366 @default.
- W2131621311 cites W2008688804 @default.
- W2131621311 cites W2009885339 @default.
- W2131621311 cites W2015568263 @default.
- W2131621311 cites W2016659805 @default.
- W2131621311 cites W2016735282 @default.
- W2131621311 cites W2021878902 @default.
- W2131621311 cites W2022999547 @default.
- W2131621311 cites W2024644107 @default.
- W2131621311 cites W2025722002 @default.
- W2131621311 cites W2028453745 @default.
- W2131621311 cites W2029388382 @default.
- W2131621311 cites W2029406046 @default.
- W2131621311 cites W2036347898 @default.
- W2131621311 cites W2037886343 @default.
- W2131621311 cites W2039004726 @default.
- W2131621311 cites W2042927558 @default.
- W2131621311 cites W2043104155 @default.
- W2131621311 cites W2043599293 @default.
- W2131621311 cites W2044718209 @default.
- W2131621311 cites W2045299787 @default.
- W2131621311 cites W2046561488 @default.
- W2131621311 cites W2048983720 @default.
- W2131621311 cites W2051055769 @default.
- W2131621311 cites W205316084 @default.
- W2131621311 cites W2053683902 @default.
- W2131621311 cites W2055181393 @default.
- W2131621311 cites W2055577394 @default.
- W2131621311 cites W2057262661 @default.
- W2131621311 cites W2057490818 @default.
- W2131621311 cites W2057769184 @default.
- W2131621311 cites W2058015212 @default.
- W2131621311 cites W2059001151 @default.
- W2131621311 cites W2059227619 @default.
- W2131621311 cites W2059800699 @default.
- W2131621311 cites W2059903231 @default.
- W2131621311 cites W2063419873 @default.
- W2131621311 cites W2063470653 @default.
- W2131621311 cites W2064840987 @default.
- W2131621311 cites W2070795385 @default.
- W2131621311 cites W2072268910 @default.
- W2131621311 cites W2072325046 @default.
- W2131621311 cites W2073024643 @default.
- W2131621311 cites W2077077967 @default.
- W2131621311 cites W2077158310 @default.
- W2131621311 cites W2077314234 @default.
- W2131621311 cites W2077515951 @default.
- W2131621311 cites W2077882848 @default.
- W2131621311 cites W2079925501 @default.
- W2131621311 cites W2082267752 @default.
- W2131621311 cites W2087510327 @default.
- W2131621311 cites W2087949958 @default.
- W2131621311 cites W2095058829 @default.
- W2131621311 cites W2097931352 @default.
- W2131621311 cites W2098369738 @default.
- W2131621311 cites W2100151922 @default.
- W2131621311 cites W2100781745 @default.
- W2131621311 cites W2101939391 @default.
- W2131621311 cites W2102432450 @default.
- W2131621311 cites W2104334201 @default.